Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma
This study is currently recruiting participants.
Verified December 2010 by Cedars-Sinai Medical Center
Sponsor:
Cedars-Sinai Medical Center
Information provided by:
Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier:
NCT00598949
First received: January 11, 2008
Last updated: December 14, 2010
Last verified: December 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to determine genetic links among blood-relatives and between spouses of patients with pituitary tumors.
| Condition |
|---|
|
Pituitary Tumor |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma |
Resource links provided by NLM:
Further study details as provided by Cedars-Sinai Medical Center:
Biospecimen Retention: Samples With DNA
Detailed Description:
cell lines are established for future genetic analysis
| Estimated Enrollment: | 600 |
| Study Start Date: | January 2003 |
| Estimated Primary Completion Date: | December 2015 (Final data collection date for primary outcome measure) |
The purpose of the family study is to investigate the genetic basis for the development of pituitary tumors by assessing the prevalence of pituitary tumors in relatives of probands with the disease as compared to the prevalence in unrelated spouses sharing a similar environment.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
tertiary referral center
Criteria
Inclusion Criteria:
- patients harboring secretory or non-secretory adenomas and/or siblings and/or spouses
Exclusion Criteria:
- patient without consenting siblings and/or siblings and/or spouses
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00598949
Contacts
| Contact: Billy Gellepis | 310-423-3395 | Billy.Gellepis@cshs.org |
| Contact: Lori korsakoff, RN | 310-423-2411 | lori.korsakoff@cshs.org |
Locations
| United States, California | |
| Cedars-Sinai Medical Center, Pituitary Center | Recruiting |
| Los Angeles, California, United States, 90048 | |
| Contact: Vivien Bonert, MD 310-423-2830 Bonertv@cshs.org | |
| Contact: Lori Korsakoff, RN 310-423-2411 lori.korsakoff@cshs.org | |
Sponsors and Collaborators
Cedars-Sinai Medical Center
Investigators
| Principal Investigator: | Vivian Bonert, MD | Cedars-Sinai Medical Center |
More Information
No publications provided
| Responsible Party: | Vivien Bonert, MD, Cedars-Sinai Medical Center, Pituitary Center |
| ClinicalTrials.gov Identifier: | NCT00598949 History of Changes |
| Other Study ID Numbers: | 3765, 3765 |
| Study First Received: | January 11, 2008 |
| Last Updated: | December 14, 2010 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Cedars-Sinai Medical Center:
|
Pituitary Adenoma Tumor |
Acromegaly Prolactinoma Cushing's |
Additional relevant MeSH terms:
|
Adenoma Pituitary Neoplasms Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Endocrine Gland Neoplasms Neoplasms by Site Hypothalamic Neoplasms Supratentorial Neoplasms |
Brain Neoplasms Central Nervous System Neoplasms Nervous System Neoplasms Brain Diseases Central Nervous System Diseases Nervous System Diseases Hypothalamic Diseases Pituitary Diseases Endocrine System Diseases |
ClinicalTrials.gov processed this record on May 22, 2013